Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Purdue Pharma and DOJ Reach Opioid Settlement
The settlement means that Purdue Pharma will plead guilty to three federal charges.
Phoenix Rising: Changing Course After Tragedy
After a devastating crash, flight paramedic Derek Boehm faced a long road to recovery. Watch how expert case management helped him reclaim his life.
Genex chronicles flight paramedic's rise from a deadly helicopter crash
‘Phoenix Rising’ video offers inside look at the important link between specialized case manager intervention and injured employee recovery
GSK Consumer Healthcare Requests Halt of Excedrin Sale & Teva Pharmaceuticals Releases Generic Truvada
Learn how these two drug updates could affect the workers' compensation and auto casualty industries.
Rising Opioid Abuse, Increasing Acceptance of Marijuana and COVID-19 Continue to Shape Pharmacy Programs
Mitchell Pharmacy Solutions 2020 Annual Clinical Review analyzes industry research crucial to guide pharmacy program strategy.
Clinical Cannabis Considerations
It seems there is always something new to say when it comes to the hot topic of medical marijuana or “cannabis,” as it’s commonly referred to in clinical literature.